449 related articles for article (PubMed ID: 30035699)
1. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.
Sabetian S; Nezafat N; Dorosti H; Zarei M; Ghasemi Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2546-2563. PubMed ID: 30035699
[TBL] [Abstract][Full Text] [Related]
2. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection.
Ali M; Pandey RK; Khatoon N; Narula A; Mishra A; Prajapati VK
Sci Rep; 2017 Aug; 7(1):9232. PubMed ID: 28835708
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
[TBL] [Abstract][Full Text] [Related]
4. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
Shahid F; Ashfaq UA; Javaid A; Khalid H
Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein.
Tahir RA; Wu H; Rizwan MA; Jafar TH; Saleem S; Sehgal SA
J Theor Biol; 2018 Dec; 459():162-170. PubMed ID: 30291844
[TBL] [Abstract][Full Text] [Related]
6. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
[TBL] [Abstract][Full Text] [Related]
7. Super epitope dengue vaccine instigated serotype independent immune protection in-silico.
Naskar S; Harsukhbhai Chandpa H; Agarwal S; Meena J
Vaccine; 2024 Jul; 42(18):3857-3873. PubMed ID: 38616437
[TBL] [Abstract][Full Text] [Related]
8. A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.
Huang X; Karabudak A; Comber JD; Philip M; Morcol T; Philip R
Hum Vaccin Immunother; 2017 Nov; 13(11):2612-2625. PubMed ID: 28933657
[TBL] [Abstract][Full Text] [Related]
9. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Neutralizing Dengue Virus B Cell Epitopes and Protective T Cell Epitopes With Those in Three Main Dengue Virus Vaccines.
Pinheiro JR; Camilo Dos Reis E; Souza RDSO; Rocha ALS; Suesdek L; Azevedo V; Tiwari S; Rocha BGS; Birbrair A; Méndez EC; Luiz WB; Amorim JH
Front Immunol; 2021; 12():715136. PubMed ID: 34489965
[TBL] [Abstract][Full Text] [Related]
11. Development of a tetravalent subunit vaccine against dengue virus through a vaccinomics approach.
Basheer A; Jamal SB; Alzahrani B; Faheem M
Front Immunol; 2023; 14():1273838. PubMed ID: 38045699
[TBL] [Abstract][Full Text] [Related]
12. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine.
Dorosti H; Eslami M; Negahdaripour M; Ghoshoon MB; Gholami A; Heidari R; Dehshahri A; Erfani N; Nezafat N; Ghasemi Y
J Biomol Struct Dyn; 2019 Aug; 37(13):3524-3535. PubMed ID: 30634893
[No Abstract] [Full Text] [Related]
13. Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.
Ahmed SF; Quadeer AA; Barton JP; McKay MR
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008676. PubMed ID: 32956362
[TBL] [Abstract][Full Text] [Related]
14. Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics.
Zhu F; Tan C; Li C; Ma S; Wen H; Yang H; Rao M; Zhang P; Peng W; Cui Y; Chen J; Pan P
Front Immunol; 2023; 14():1100188. PubMed ID: 36845087
[TBL] [Abstract][Full Text] [Related]
15. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
[TBL] [Abstract][Full Text] [Related]
16. Immuno-informatics guided designing of a multi-epitope vaccine against Dengue and Zika.
Bhardwaj A; Sharma R; Grover A
J Biomol Struct Dyn; 2023 Jan; 41(1):1-15. PubMed ID: 34796791
[TBL] [Abstract][Full Text] [Related]
17. Immunoinformatics designed T cell multi epitope dengue peptide vaccine derived from non structural proteome.
Krishnan G S; Joshi A; Akhtar N; Kaushik V
Microb Pathog; 2021 Jan; 150():104728. PubMed ID: 33400987
[TBL] [Abstract][Full Text] [Related]
18. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
Ahmad S; Ranaghan KE; Azam SS
Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
[TBL] [Abstract][Full Text] [Related]
19. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
20. Design of a multi-epitope Zika virus vaccine candidate - an
Ezzemani W; Windisch MP; Altawalah H; Guessous F; Saile R; Benjelloun S; Kettani A; Ezzikouri S
J Biomol Struct Dyn; 2023 Jun; 41(9):3762-3771. PubMed ID: 35318896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
